A carregar...
Progression after Immunotherapy for Fibrolamellar Carcinoma
BACKGROUND: Fibrolamellar carcinoma (FLC) is a rare malignancy of the liver that differs from typical hepatocellular carcinoma (HCC) in several aspects such as the absence of underlying liver disease and occurrence in younger patients. Even though the survival rates in FLC are slightly better than i...
Na minha lista:
| Publicado no: | Visc Med |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6597907/ https://ncbi.nlm.nih.gov/pubmed/31312648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000497464 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|